Boehringer Ingelheim‘s BI 695501 has been deemed effectively equivalent to Humira (adalimumab) in patients with active rheumatoid arthritis (RA), according to the ... Read more
Inflammation in people with rheumatoid arthritis may be promoted by a group of proteins, called amylase-trypsin inhibitors (ATIs), that are commonly found in ... Read more